A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
Phase 1 Completed
23 enrolled
Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma
Phase 1 Completed
49 enrolled
Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor
Phase 1 Completed
25 enrolled
MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors
Phase 1 Completed
7 enrolled
Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors
Phase 1 Completed
24 enrolled
A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard Therapy
Phase 1 Completed
62 enrolled
ASCR
Phase 1 Completed
14 enrolled
AflacST1501
Phase 1 Completed
53 enrolled
Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803
Phase 1 Completed
14 enrolled
TAA-Specific CTLS for Solid Tumors (TACTASOM)
Phase 1 Completed
16 enrolled
Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors
Phase 1 Completed
25 enrolled
Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK)
Phase 1 Completed
83 enrolled 30 charts
Aflac ST0901
Phase 1 Completed
18 enrolled
AflacST1402
Phase 1 Completed
13 enrolled
Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy
Phase 1 Completed
34 enrolled
A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation From Related or Matched Unrelated Donors in Pediatric Patients With Solid Tumors and Leukemias
Phase 1 Completed
34 enrolled 19 charts
HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors
Phase 1 Completed
18 enrolled
Tabectedin to Treat Children and Adolescents With Cancer
Phase 1 Completed
12 enrolled
Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma
Phase 1 Completed
19 enrolled
PK/PD of XM22 in Children With Ewing Family of Tumors or Rhabdomyosarcoma
Phase 1 Completed
21 enrolled
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
Phase 1 Completed
30 enrolled
Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients
Phase 1 Completed
6 enrolled
Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors
Phase 1 Completed
41 enrolled
Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors
Phase 1 Completed
17 enrolled
Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
Phase 1 Completed
28 enrolled
ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors
Phase 1 Completed
19 enrolled
Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer
Phase 1 Completed
10 enrolled
Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma
Phase 1 Completed
16 enrolled